Genetic analysis of NR4A2 gene in a large population of Han Chinese patients with Parkinson's disease

European Journal of Neurology

Volumn 20, Issue 3, 2013, Pages 584-587

  Liu, H ^a   Tao, Q ^a   Deng, H ^b   Ming, M ^a   Ding, Y ^a   Xu, P ^c   Chen, S ^a   Song, Z ^b   Le, W ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Genetic analysis; NR4A2 gene; Parkinson's disease

Indexed keywords

NUCLEAR RECEPTOR RELATED FACTOR 1;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CHINESE; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENE INSERTION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PARKINSON DISEASE;

EID: 84874000386     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03824.x     Document Type: Article

References (11)

1. Bensinger SJ, Tontonoz P. A Nurr1 pathway for neuroprotection. Cell 2009; 137: 26-28.
2. Sakurada K, Ohshima-Sakurada M, Palmer TD, Gage FH. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 1999; 126: 4017-4026.
3. Xu PY, Liang R, Jankovic J, et al. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Neurology 2002; 58: 881-884.
4. Le WD, Xu P, Jankovic J, et al. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 2003; 33: 85-89.
5. Zheng K, Heydari B, Simon DK, Zheng K, Heydari B, Simon DK. A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease. Arch Neurol 2003; 60: 722-725.
6. Grimes DA, Han F, Panisset M, et al. Translated mutation in the Nurr1 gene as a cause for Parkinson's disease. Mov Disord 2006; 21: 906-909.
7. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-191.
8. Levecque C, Destee A, Mouroux V, Amouyel P, Chartier-Harlin MC. Assessment of Nurr1 nucleotide variations in familial Parkinson's disease. Neurosci Lett 2004; 366: 135-138.
9. Hering R, Petrovic S, Mietz EM, et al. Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease. Neurology 2004; 62: 1231-1232.
10. Healy DG, Abou-Sleiman PM, Ahmadi KR, et al. NR4A2 genetic variation in sporadic Parkinson's disease: a genewide approach. Mov Disord 2006; 21: 1960-1963.
11. Wellenbrock C, Hedrich K, Schafer N, et al. NR4A2 mutations are rare among European patients with familial Parkinson's disease [1]. Annals of Neurology 2003; 54: 415.